Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $138.2800 (0.49%) ($137.0500 - $138.8200) on Thu. Nov. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.07% (three month average) | RSI | 50 | Latest Price | $138.2800(0.49%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -1.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(68%) IBB(60%) DIA(47%) XBI(47%) SPLV(44%) | Factors Impacting ABBV price | ABBV will decline at least -0.535% in a week (0% probabilities). VXX(-52%) VIXM(-27%) USO(-26%) GLD(-26%) BNDX(-21%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.535% (StdDev 1.07%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $136.36(-1.39%) | Resistance Level | $141.42 | 5 Day Moving Average | $138.23(0.04%) | 10 Day Moving Average | $139.51(-0.88%) | 20 Day Moving Average | $141.42(-2.22%) | To recent high | -10.6% | To recent low | 0.5% | Market Cap | $243.965b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |